Interactive Medical Technologies
This article was originally published in The Gray Sheet
Executive Summary
Completes a $900,000 private placement to "foreign investors." The placement, according to the firm, is in exchange for a one-year note that can be converted into unregistered shares invalid for sale in the U.S. The proceeds of the placement will be used for working capital and to fund the firm's R&D programs, particularly those in the "area of human contrast microspheres," the Los Angeles-based company says. Interactive, which is developing microspheres designed to improve computed axial tomography, magnetic resonance and ultrasound images, says that it has raised a total of $1.6 mil. in financing this year